Literature DB >> 27461878

Changes in serum lipid profile in the acute and convalescent Plasmodium vivax malaria: A cohort study.

Teresinha C Mesquita1, Thamires G O Martin1, Eduardo R Alves2, Marcia B C Mello1, Andreia F Nery3, Luciano T Gomes1, Cor Jesus F Fontes4.   

Abstract

Although serum lipids are known to be altered in Plasmodium falciparum-induced malaria, little is known about such changes due to Plasmodium vivax infection. This cohort study assessed serum concentrations of triglycerides, total cholesterol, low-density lipoprotein (LDL), and high-density lipoprotein (HDL) in 164 patients in the acute phase of malaria caused by P. vivax and characterized these changes in the convalescent phase after treatment with chloroquine and primaquine. Compared to reference values, serum total cholesterol, LDL, and HDL levels were lower and triglyceride levels were higher in the acute phase. Moreover, the parasite density was negatively correlated with LDL (r=-0,189; p=0.027) and HDL (r=-0,256; p=0.001) serum levels. Eighty patients returned for clinical and laboratory revaluation 7-12days after treatment initiation. All patients showed parasite clearance and the absence of symptoms during the convalescent phase. Analysis of the serum lipids of these 80 patients showed significant increases in the serum levels of total cholesterol (p<0.0001), LDL (p<0.0001), and HDL (p<0.0001) as well as a significant reduction in triglycerides (p=0.004), indicating a trend towards a return to normal levels. This transient change in lipid profile between the acute and convalescent stages may be useful for the clinical monitoring of patients treated for vivax malaria.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Lipids; Malaria; Plasmodium vivax

Mesh:

Substances:

Year:  2016        PMID: 27461878     DOI: 10.1016/j.actatropica.2016.07.010

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  4 in total

1.  Serum Lipids and Lipoproteins During Uncomplicated Malaria: A Cohort Study in Lambaréné, Gabon.

Authors:  Benjamin J Visser; Sophia G de Vries; Rieke Vingerling; Martin Gritter; Danielle Kroon; Lídia Ciudad Aguilar; Rik B J Kraan; Rosanne W Wieten; François Danion; Barbara Sjouke; Akim A Adegnika; Selidji T Agnandji; Peter G Kremsner; Thomas Hänscheid; Petra F Mens; Michèle van Vugt; Martin P Grobusch
Journal:  Am J Trop Med Hyg       Date:  2017-05       Impact factor: 2.345

2.  Metabolome-wide association study of peripheral parasitemia in Plasmodium vivax malaria.

Authors:  Luiz Gustavo Gardinassi; Regina Joice Cordy; Marcus V G Lacerda; Jorge L Salinas; Wuelton M Monteiro; Gisely C Melo; André M Siqueira; Fernando F Val; ViLinh Tran; Dean P Jones; Mary R Galinski; Shuzhao Li
Journal:  Int J Med Microbiol       Date:  2017-09-06       Impact factor: 3.473

3.  Aspartate aminotransferase-to-platelet ratio index (APRI): A potential marker for diagnosis in patients at risk of severe malaria caused by Plasmodium vivax.

Authors:  Karla Sena Guedes; Bruno Antônio Marinho Sanchez; Luciano Teixeira Gomes; Cor Jesus Fernandes Fontes
Journal:  PLoS One       Date:  2019-11-25       Impact factor: 3.240

4.  New laboratory perspectives for evaluation of vivax malaria infected patients: a useful tool for infection monitoring.

Authors:  Eduardo Rodrigues Alves-Junior; Luciano Teixeira Gomes; Thaís Caroline Dallabona Dombroski; Andréia Ferreira Nery; Samuel Vandresen-Filho; Luciano Nakazato; Cor Jesus Fernandes Fontes; Fabrício Rios-Santos
Journal:  Braz J Infect Dis       Date:  2020-04-23       Impact factor: 3.257

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.